OKLAHOMA CITY – Rep. Jacob Rosecrants, D-Norman, will lead an interim study examining medical marijuana testing, transparency, and public health outcomes.
The study will evaluate Oklahoma’s current regulatory framework for marijuana testing, product safety, and consumer transparency. It will also go over existing testing standards, compliance requirements, product recall processes, and oversight mechanisms to identify strengths, gaps, and opportunities for improvement within the state’s medical marijuana program.
“Medical marijuana patients in Oklahoma deserve to know that the products they rely on are safe, accurately tested, and held to consistent standards,” said Rosecrants. “This interim study is an opportunity to bring regulators, patients, laboratories, and industry stakeholders to the same table, examine what’s working and what isn’t, and identify ways to strengthen safety, transparency, accountability, and public confidence in Oklahoma’s medical marijuana program.”
The objective of this study is to bring experts together to identify practical policy solutions that work to increase transparency and strengthen consumer protections in order to create an overall safer and more effective medical marijuana marketplace for Oklahoma patients.
This study is scheduled to be held on October 13, 2026, from 9:30 a.m. to 12:30 p.m. and will be livestreamed on the Oklahoma House of Representatives website.
